DE3789400D1 - Für ein Glykoprotein des AIDS-Virus kodierende Virus-Vektoren, Vakzin und Antikörper. - Google Patents
Für ein Glykoprotein des AIDS-Virus kodierende Virus-Vektoren, Vakzin und Antikörper.Info
- Publication number
- DE3789400D1 DE3789400D1 DE87400790T DE3789400T DE3789400D1 DE 3789400 D1 DE3789400 D1 DE 3789400D1 DE 87400790 T DE87400790 T DE 87400790T DE 3789400 T DE3789400 T DE 3789400T DE 3789400 D1 DE3789400 D1 DE 3789400D1
- Authority
- DE
- Germany
- Prior art keywords
- virus
- glycoprotein
- vaccine
- aids
- antibodies encoding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000003886 Glycoproteins Human genes 0.000 title abstract 3
- 108090000288 Glycoproteins Proteins 0.000 title abstract 3
- 241000700605 Viruses Species 0.000 title abstract 3
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000013603 viral vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- AIDS & HIV (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8605043A FR2596771B1 (fr) | 1986-04-08 | 1986-04-08 | Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus |
FR8615106A FR2606029B2 (fr) | 1986-04-08 | 1986-10-29 | Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3789400D1 true DE3789400D1 (de) | 1994-04-28 |
DE3789400T2 DE3789400T2 (de) | 1994-09-01 |
Family
ID=26225146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3789400T Expired - Lifetime DE3789400T2 (de) | 1986-04-08 | 1987-04-08 | Für ein Glykoprotein des AIDS-Virus kodierende Virus-Vektoren, Vakzin und Antikörper. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0245136B1 (de) |
JP (3) | JP2719917B2 (de) |
KR (1) | KR960001819B1 (de) |
AT (1) | ATE103328T1 (de) |
AU (1) | AU604696B2 (de) |
CA (1) | CA1341353C (de) |
DE (1) | DE3789400T2 (de) |
DK (1) | DK175613B1 (de) |
ES (1) | ES2052589T3 (de) |
FR (1) | FR2606029B2 (de) |
PT (1) | PT84640B (de) |
WO (1) | WO1987006260A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5681713A (en) * | 1987-05-08 | 1997-10-28 | Smithkline Beecham Corporation | Expression of heterologous proteins in Drosophila cells |
US6133029A (en) * | 1988-03-21 | 2000-10-17 | Chiron Corporation | Replication defective viral vectors for infecting human cells |
IL89567A0 (en) * | 1988-03-28 | 1989-09-10 | Univ Leland Stanford Junior | Mutated hiv envelope protein |
US5614404A (en) * | 1988-06-10 | 1997-03-25 | Theriod Biologics, Incorporated | Self-assembled, defective, non-self-propagating lentivirus particles |
US5747324A (en) * | 1988-06-10 | 1998-05-05 | Therion Biologics Corporation | Self-assembled, defective, non-self-propagating lentivirus particles |
AU3775789A (en) * | 1988-06-10 | 1990-01-05 | Applied Biotechnology, Inc. | A method of evaluating recombinant vaccines against immunodeficiency virus |
ATE108335T1 (de) * | 1989-03-03 | 1994-07-15 | Microgenesys Inc | Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen. |
EP0897987B1 (de) * | 1989-10-24 | 2001-02-28 | Chiron Corporation | Sekretion vom mit Gamma-Interferon Signalpeptid gebundenen humänen Protein |
US5817491A (en) * | 1990-09-21 | 1998-10-06 | The Regents Of The University Of California | VSV G pseusdotyped retroviral vectors |
US6228608B1 (en) * | 1991-02-28 | 2001-05-08 | Aquila Biopharmaceuticals, Inc. | Recombinant FIV glycoprotein 160 and P24 gag protein |
FR2676071B1 (fr) * | 1991-05-02 | 1994-11-18 | Transgene Sa | Nouveau variant gp160 non-clivable, soluble, de forme hybride. |
GB9215233D0 (en) * | 1992-07-17 | 1992-09-02 | Pitman Moore Inc | Vaccines |
US5888814A (en) * | 1994-06-06 | 1999-03-30 | Chiron Corporation | Recombinant host cells encoding TNF proteins |
FR2766091A1 (fr) * | 1997-07-18 | 1999-01-22 | Transgene Sa | Composition antitumorale a base de polypeptide immunogene de localisation cellulaire modifiee |
CA2531773A1 (en) | 2003-07-21 | 2005-02-17 | Transgene S.A. | Novel multifunctional cytokines |
CN1304580C (zh) * | 2004-07-09 | 2007-03-14 | 楼伟 | 重组表达人获得性免疫缺陷病毒I型的表面糖蛋白gp160 |
WO2014009433A1 (en) | 2012-07-10 | 2014-01-16 | Transgene Sa | Mycobacterium resuscitation promoting factor for use as adjuvant |
CN104870477B (zh) | 2012-10-23 | 2018-10-09 | 爱默蕾大学 | Gm-csf和il-4轭合物、组合物以及与其相关的方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA867281B (en) * | 1985-09-25 | 1987-05-27 | Oncogen | Vaccines and immunoassays for acquired immune deficiency syndrome |
EP0243029A1 (de) * | 1986-04-08 | 1987-10-28 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Rekombinantes Vaccinia-Virus, das ein menschliches Retrovirus-Gen ausdrückt |
-
1986
- 1986-10-29 FR FR8615106A patent/FR2606029B2/fr not_active Expired
-
1987
- 1987-04-08 CA CA000534170A patent/CA1341353C/fr not_active Expired - Lifetime
- 1987-04-08 PT PT84640A patent/PT84640B/pt unknown
- 1987-04-08 ES ES87400790T patent/ES2052589T3/es not_active Expired - Lifetime
- 1987-04-08 AT AT87400790T patent/ATE103328T1/de not_active IP Right Cessation
- 1987-04-08 EP EP87400790A patent/EP0245136B1/de not_active Expired - Lifetime
- 1987-04-08 DE DE3789400T patent/DE3789400T2/de not_active Expired - Lifetime
- 1987-04-08 AU AU72349/87A patent/AU604696B2/en not_active Expired
- 1987-04-08 WO PCT/FR1987/000116 patent/WO1987006260A1/fr unknown
- 1987-04-08 JP JP62502264A patent/JP2719917B2/ja not_active Expired - Lifetime
- 1987-12-07 DK DK198706417A patent/DK175613B1/da active
- 1987-12-08 KR KR87701159A patent/KR960001819B1/ko not_active IP Right Cessation
-
1995
- 1995-10-25 JP JP7277533A patent/JP2743164B2/ja not_active Expired - Lifetime
-
1997
- 1997-05-21 JP JP9131138A patent/JPH1059868A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2606029A2 (fr) | 1988-05-06 |
EP0245136B1 (de) | 1994-03-23 |
DK175613B1 (da) | 2004-12-27 |
JP2719917B2 (ja) | 1998-02-25 |
CA1341353C (fr) | 2002-04-02 |
EP0245136A1 (de) | 1987-11-11 |
AU7234987A (en) | 1987-11-09 |
FR2606029B2 (fr) | 1989-02-03 |
JPH08224090A (ja) | 1996-09-03 |
PT84640A (fr) | 1987-05-01 |
DK641787A (da) | 1987-12-07 |
JPH1059868A (ja) | 1998-03-03 |
ATE103328T1 (de) | 1994-04-15 |
KR880701283A (ko) | 1988-07-26 |
AU604696B2 (en) | 1991-01-03 |
WO1987006260A1 (fr) | 1987-10-22 |
JP2743164B2 (ja) | 1998-04-22 |
KR960001819B1 (en) | 1996-02-05 |
DE3789400T2 (de) | 1994-09-01 |
ES2052589T3 (es) | 1994-07-16 |
JPH01500161A (ja) | 1989-01-26 |
DK641787D0 (da) | 1987-12-07 |
PT84640B (pt) | 1989-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3789400T2 (de) | Für ein Glykoprotein des AIDS-Virus kodierende Virus-Vektoren, Vakzin und Antikörper. | |
CY1113731T1 (el) | Μεθοδοι για δημιουργια παρασκευασματων κομιστων ανασυνδυασμενου aav υψηλου τιτλου απαλλαγμενων απο βοηθητικο ιο | |
MX9603002A (es) | Procedimiento para la preparacion de virus asociados a los adenovirus (aav), recombinantes, y usos de los mismos. | |
CZ63995A3 (en) | Virus vectors and their use in gene therapy | |
DK33190A (da) | Hiv-3 retrovirus og anvendelse heraf | |
DE68927025D1 (de) | HIV-2-Virusvarianten | |
AU580059B2 (en) | Vaccine against rabies and preparation process thereof | |
NZ226904A (en) | Hiv-2 env protein polypeptides and their preparation and use | |
MXPA02012593A (es) | Particulas de tipo virus del virus de la diarrea viral bovina. | |
PT975783E (pt) | "vectores retrovirais, processo para a sua producao e sua utilizacao para a transferencia de genes a celulas cd4-positivas" | |
DK76688D0 (da) | Vaccine indeholdende f-proteinet fra aids-virus | |
DK498387A (da) | Virus-dna-sekvens | |
DK631387A (da) | Virusvektor | |
ES2054841T3 (es) | Vector viral y adn recombinante que codifica para una o unas proteinas de estructura (ha, f y/o np), de un morbilivirus. | |
AP1561A (en) | Use of non-cytolytic retrovirus as vaccines for the treatment of HIV infection. | |
TH33841A (th) | รีคอมบิแนนท์เอวิพอคซ์ไวรัส การเพาะเลี้ยงเซลล์ที่ติดเชื้อไวรัสนี้ และวัคซีนสำหรับสัตว์ปีกที่อนุพัทธ์จากไวรัสนี้ | |
TH33841EX (th) | รีคอมบิแนนท์เอวิพอคซ์ไวรัส การเพาะเลี้ยงเซลล์ที่ติดเชื้อไวรัสนี้ และวัคซีนสำหรับสัตว์ปีกที่อนุพัทธ์จากไวรัสนี้ | |
GT198304126A (es) | Produccion de proteinas del virus de herpes simplex |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |